From:                                         Auzina-Vundere Agnese

Sent:                                           27 November 2020 17:02

To:                                               All Human CHMP

Cc:                                               Seguin Vanessa; Rager Irene; COVID-19.mRNA.Vaccine.BioNTech-5735

Subject:                                     Written procedure for COVID-19.mRNA.Vaccine.BioNTech-5735 – for your comments by 30/11 17:00 CET

 

 

Dear CHMP members,

 

Please find linked below the CHMP Interim Opinion together with the CHMP Overview and LoQ for COVID-19.mRNA.Vaccine.BioNTech-5735 relating to quality data only.

 

Please kindly review it and let us know if you have any comments. Considering the urgency of this endorsement, please respond by 17:00 CET Monday 30th of November 2020.

 

https://eudralink.ema.europa.eu/dl.php?d=718f33cfe2fa1c12be533775e6f26d21

 

 

In the absence of comments by the above date, the request will be considered adopted.

 

 

Thank you and kind regards

 

 

3-EMA banner - option 1

Agnese Auzina-Vundere

Procedure Assistant

Vaccines and therapies for infectious diseases
Human Medicines Division

 

Desk 11-N-35 | Ext. 7668